Molecular mechanisms in signal transduction and cancer: Meeting on oncogenes & growth control

EMBO Reports

Volumn 5, Issue 9, 2004, Pages 855-859

  Bos, Johannes L ^a   Burgering, Boudewijn M T ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; B LYMPHOCYTE RECEPTOR; B RAF KINASE; BETA CATENIN; BETA GALACTOSIDASE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CYTOKINE; DOXORUBICIN; GROWTH FACTOR; GUANOSINE TRIPHOSPHATASE; IMATINIB; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE INHIBITOR; PROTEIN P53; PROTEINASE; RAPAMYCIN; RAS PROTEIN; SHORT HAIRPIN RNA; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR PU 1; TUMOR SUPPRESSOR PROTEIN; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3; PHOSPHOTRANSFERASE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANGIOGENESIS; CARCINOGENESIS; CELL AGING; CELL RENEWAL; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; ENZYME CONFORMATION; ENZYME INHIBITION; GENE MUTATION; GROWTH REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; LYMPHANGIOGENESIS; MALIGNANT NEOPLASTIC DISEASE; METASTASIS POTENTIAL; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; NEOPLASM; PHYSIOLOGY;

ANIMALS; GTP PHOSPHOHYDROLASES; HEDGEHOG PROTEINS; HUMANS; NEOPLASMS; PHOSPHOTRANSFERASES; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 16644378176     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400220     Document Type: Conference Paper

References (11)

1. Aslanian A, Iaquinta PJ, Verona R, Lees JA (2004) Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev 18: 1413-1422
2. Baas AF, Kuipers J, van der Wel NN, Batlle E, Koerten HK, Peters PJ, Clevers HC (2004) Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 116: 457-466
3. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, Hardie DG (2003) Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2: 28
4. Lizcano JM et al (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 23 833-843
5. Lum L, Beachy PA (2004) The Hedgehog response network: Sensors, switches, and routers. Science 304: 1755-1759
6. Miralles F, Posern G, Zaromytidou AI, Treisman R (2003) Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113: 329-342
7. Saharinen P. Tammela T, Karkkainen MJ, Alitalo K (2004) Lymphatic vasculature: Development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25: 387-395
8. Wan PT et al (2004) Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutation of B-RAF. Cell 116: 855-867
9. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW (2004) Survival signalling by Akt and elF4E in oncogenesis and cancer therapy. Nature 428: 332-337
10. Woodring PJ, Meisenhelder J, Johnson SA, Zhou GL, Field J, Shah K, Bladi F, Rawson T, Niki M, Pandolfi PP, Wang JY, Hunter T (2004) c-Abl phosphorylates Dok1 to promote filopodia during cell spreading. J Cell Biol 165: 493-503
11. Xie H, Ye M, Feng R, Graf T (2004) Stepwise reprogramming of B cells into macrophages. Cell 117: 663-676